Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029089 (
ophthalmoplegia
)
3,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Atypical
hemolytic uremic syndrome
(
HUS
) is a subtype of thrombotic microangiopathy associated with complement alternative pathway dysregulation. It is clinically characterized by a relapsing course and a poor prognosis. Multiple organ systems are commonly affected by thrombotic microangiopathy in pediatric atypical
HUS
; however, ocular involvement is rarely reported. The case of an 11-year-old girl diagnosed as having atypical
HUS
who presented with bilateral central retinal vein occlusions with macular subhyaloid hemorrhage during her initial onset and
ophthalmoplegia
, diplopia, and optic disc edema during her relapsing episode 1 year later is described. All ocular manifestations occurred in the convalescence phase of atypical
HUS
. No other extrarenal complications were found and full recovery was achieved following typical treatment for atypical
HUS
(ie, plasma infusion, steroid, and supportive therapy). This is thought to be the first reported case of recurrent ocular involvement in pediatric atypical
HUS
.
...
PMID:Recurrent ocular involvement in pediatric atypical hemolytic uremic syndrome. 2534 82
Atypical
hemolytic uremic syndrome
(
HUS
) is a subtype of thrombotic microangiopathy associated with complement alternative pathway dysregulation. It is clinically characterized by a relapsing course and a poor prognosis. Multiple organ systems are commonly affected by thrombotic microangiopathy in pediatric atypical
HUS
; however, ocular involvement is rarely reported. The case of an 11-year-old girl diagnosed as having atypical
HUS
who presented with bilateral central retinal vein occlusions with macular subhyaloid hemorrhage during her initial onset and
ophthalmoplegia
, diplopia, and optic disc edema during her relapsing episode 1 year later is described. All ocular manifestations occurred in the convalescence phase of atypical
HUS
. No other extrarenal complications were found and full recovery was achieved following typical treatment for atypical
HUS
(ie, plasma infusion, steroid, and supportive therapy). This is thought to be the first reported case of recurrent ocular involvement in pediatric atypical
HUS
.
...
PMID:Recurrent ocular involvement in pediatric atypical hemolytic uremic syndrome. 2560 28